Hi Kenbe hope you are well. Of course urgentrx has noting
Hi Kenbe hope you are well. Of course urgentrx has noting to do with scrc. That particular poster is an embarassment to their cause as he clearly comes off like a jackal. His/her arguements quite frankly are at a 1st grade level in my opinion. It comes off as childish.
If we maintain 5m to 5.5m for the next 9 months scrc will have a lot of cash on hand. so if we are able to sustain a rr of 60M for the next 9 months or so we will be in tremendous shape as a company. Even if rapimeds doesn't happen the company is worth far more than .10 to .13 cents over the next 6 to 10 quarters.
I believe more eyes will be on us in the next 4 to 8 weeks and nov 12th is a nice intial start to getting the word out. Its clear since we have done back to back 5m months the company can now start spending $ to broaden the focus on the street. On the retail front if we see another 75 to 100 people get involved it will clear away most overhang. I believe that all the overhang will be gone in the next 9 months from today. When that happens the stock will perform far better than .10 to .13.
Its an exciting time to be an scrc shareholder as the turnaround here as a company is miraculous. The stock is doing a little better and should do very well over the next 3 to 6 quarters.
ScripsAmerica Inc (SCRC) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A New Chapter in the AI Narrative Take a seat, folks, because we're watching AI swing from showy tech to something as plain as plumbing infrastructure. Imagine models that once cost bundles per token now going for peanuts. We're talking a nosedive from $37.50 to a mere 18 cents. It’s a seismic shift, steering the conversation from 'Are they the best models?' to 'How...
Continue Reading
Mac Cummings: A Maverick at Terakeet's Helm So, here’s the deal—we’ve got Mac Cummings, a guy who's shaking up the marketing world just when we thought we had it all figured out. When you get a nod from ADWEEK's Innovator 50, it isn't because you played it safe. It's because you believed in disrupting the status quo. Cummings has taken Terakeet from a humble start...
Continue Reading
The Surging Demand for Tea Extracts The tea extract market's carving out quite a niche for itself. From $3.22 billion in 2026, it's primed to scale up to a cool $4.70 billion by 2031. That's a steady 7.9% growth rate, and it's just fueled by the booming demand for all things natural and health-oriented. Natural and Functional: Key Industry Drivers Consumers these days...
Continue Reading
China's Health Strategy in Poverty Reduction Here's a story that's got global implications tucked into its every corner: China, a country that's been trying to mesh healthcare with poverty reduction, has caught the eye of international observers. This insight was splashed across the latest Lancet Commission report, showcased at Tsinghua University on October 29. It seems...
Continue Reading
Leadership Shifts in Gallagher's Upper Echelons What a shake-up at Arthur J. Gallagher & Co.! The power torch is officially passing over in its Benefits & HR Consulting Division. Come January 1, 2027, Tom Doyle is strapping in as the new CEO, taking over from William F. "Bill" Ziebell. Now, don't get too teary-eyed—Ziebell's not vanishing into thin air. Instead, he's...
Continue Reading
Omnissa Rolls Out AI Sovereignty Across New Markets In the world of AI, where data is king and control is the crown, Omnissa is making bold moves with its latest expansion announcement. The company's Sovereign Solution (OSS) is now reaching into six fresh markets across Europe and Asia, offering organizations a vital grip on their digital domains like never before. Talk...
Continue Reading
Q32 Bio Steers Forward: New Insights from Chief Results Today's update isn't just another quarterly snooze-fest—it’s a nudge in a crucial direction for Q32 Bio (NASDAQ:QTTB). After a bold brush with the European Academy of Dermatology and Venereology (EADV) Congress 2026, the company laid out a plan and a half, showing its hand with bempikibart for alopecia areata...
Continue Reading
Funny how some folks think life has a road map. Let me tell you, it's more like a pinball machine, barely controllable and ready to surprise you with a tilt at any moment. And that's the essence of Marshall Barber's new memoir, 'PINBALL: Remembrances of a Flaneur.' Life's Roulette: Choices and Chance Barber takes readers on a raw ride through the byways of a life...
Continue Reading
A Young Racer's Roaring Start Every once in a while, a kid shows up on the scene who just makes you sit up and pay attention. Enter Zayne Burgess, a mere 10-year-old with the skill set of a seasoned pro. If you care about the future of racing, you better start watching this young'un, because he's chasing a Formula 1 dream and has K1 Speed putting their chips on him....
Continue Reading
A New Chapter for an Old Favorite Dust off your digital pets, folks! Tamagotchi is not just a thing of the past. It's busting out of its shell to celebrate a big 3-0 with a splash—and get this—on Roblox. Who would've thought a plastic egg with pixels would still be out there thriving in the ether of childhood nostalgia three decades later? But it is, and it’s taking...
Continue Reading
Top 5 Most Recently Viewed Articles
Understanding Recent Insider Transactions at Tanger Inc. A noteworthy insider sell has surfaced recently, involving Joseph Thomas Guerrieri JR, who serves as Senior Vice President at Tanger (NYSE: SKT). The details of this transaction arose from a recent filing with the SEC, highlighting a substantial move by an insider. Transaction Overview: JR opted to divest 3,000...
Continue Reading
The Remarkable Growth of Charles Schwab Stock Over the past 20 years, Charles Schwab has consistently outperformed the overall market, showcasing a remarkable annualized return of 10.34%. This impressive performance has led to a market capitalization of approximately $141.73 billion. Understanding how this growth can translate for individual investors can provide valuable...
Continue Reading
Exciting New Community Opening in Tolleson Richmond American Homes is thrilled to announce the grand opening of the Seasons at Vista Del Sur community. This new development promises to be a welcoming place for families and individuals looking to settle in a vibrant environment. With an impressive range of single- and two-story homes, Richmond American is committed to...
Continue Reading
Rocket Lab Chosen for Groundbreaking NASA Mars Study Rocket Lab USA, Inc. (NASDAQ: RKLB) has an exciting opportunity in store as it embarks on a study for NASA's Mars Sample Return Program. This initiative is poised to be a historic endeavor, aiming to retrieve Martian rock samples and analyze them on Earth—offering unprecedented insights into Mars and the potential for...
Continue Reading
A Robust Quarter for ASE Technology Alright, sit down and buckle up because ASE Technology (NYSE: ASX) just dropped some eye-popping numbers for Q2 2026. This isn't some mild market fluctuation—this is what you call a serious win in the semiconductor game. With net revenues soaring to NT$191,064 million, it’s about 26.7% up from the same quarter last year. Now, that's...
Continue Reading